The least-squares mean difference in the Hammersmith Functional Motor Scale-Expanded change from baseline at 12 months was 1.8 points for those 2 to 12 years receiving apitegromab vs placebo.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback